Glioblastoma (GBM) is an aggressive, fatal and malignant primary brain tumor. Despite the
current standard treatment for glioblastoma patients including neurosurgical resection …

Glioblastoma is the most common type of primary brain tumor, which has a high recurrence
rate and a high mortality rate. Immunotherapy shows promise in cancer therapy due to its …

Background Intratumoral heterogeneity is the primary challenge in the treatment of
glioblastoma (GBM). The presence of glioma stem cells (GSCs) and their conversion …

Background RNA-binding proteins (RBPs) and circular RNAs (circRNAs) play important
roles in glioblastoma multiforme (GBM). Aerobic glycolysis is a metabolic characteristic of …

A major hallmark of neuroinflammation is the activation of microglia and astrocytes with the
induction of inflammatory mediators such as IL‐1β, TNF‐α, iNOS, and IL‐6 …

Microglial activation with the production of pro-inflammatory mediators such as IL-6, TNF-α,
and IL-1β, is a major driver of neuropathic pain (NP) following peripheral nerve injury. We …

This review is devoted to changes in the post-transcriptional maturation of RNA in human
glioblastoma cells, which leads to disruption of the normal course of apoptosis in them. The …

The exon junction complex (EJC) plays key roles throughout the lifespan of RNA and is
particularly relevant in the nervous system. We investigated the roles of two EJC members …

Glioblastoma (GBM), the most lethal primary brain cancer, exhibits intratumoral
heterogeneity and molecular plasticity, posing challenges for effective treatment. Despite …

Aging impairs osteoblast function and bone turnover, resulting in age‐related bone
degeneration. Stress granules (SGs) are membrane‐less organelles that assemble in …